Plasma vaporization for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety

CADTH
Record ID 32014000880
English
Authors' recommendations: One randomized controlled trial and six non-randomized studies were identified regarding the safety of plasma vaporization of the prostate for the treatment of patients with benign prostatic hypertrophy. No studies were identified regarding the clinical or cost-effectiveness of plasma vaporization of the prostate compared with the use of GreenLight laser for the treatment of patients with benign prostatic hypertrophy.
Details
Project Status: Completed
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Electrosurgery
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.